Correlation Between Pharmacom Biovet and Ingen Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmacom Biovet and Ingen Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmacom Biovet and Ingen Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmacom Biovet and Ingen Technologies, you can compare the effects of market volatilities on Pharmacom Biovet and Ingen Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmacom Biovet with a short position of Ingen Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmacom Biovet and Ingen Technologies.

Diversification Opportunities for Pharmacom Biovet and Ingen Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pharmacom and Ingen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmacom Biovet and Ingen Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ingen Technologies and Pharmacom Biovet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmacom Biovet are associated (or correlated) with Ingen Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ingen Technologies has no effect on the direction of Pharmacom Biovet i.e., Pharmacom Biovet and Ingen Technologies go up and down completely randomly.

Pair Corralation between Pharmacom Biovet and Ingen Technologies

If you would invest  0.00  in Ingen Technologies on October 12, 2024 and sell it today you would earn a total of  0.00  from holding Ingen Technologies or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Pharmacom Biovet  vs.  Ingen Technologies

 Performance 
       Timeline  
Pharmacom Biovet 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharmacom Biovet has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Pharmacom Biovet is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Ingen Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ingen Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ingen Technologies is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pharmacom Biovet and Ingen Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmacom Biovet and Ingen Technologies

The main advantage of trading using opposite Pharmacom Biovet and Ingen Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmacom Biovet position performs unexpectedly, Ingen Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ingen Technologies will offset losses from the drop in Ingen Technologies' long position.
The idea behind Pharmacom Biovet and Ingen Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges